Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3331-3334

  Villunger, Andreas ^a   Egle, Alexander ^a   Kos, Marion ^a   Hartmann, Bernd L ^a   Geley, Stephan ^a   Kofler, Reinhard ^a   Greil, Richard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FAS ANTIGEN; FLUDARABINE; LIGAND;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THERAPY;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DOXORUBICIN; FAS LIGAND PROTEIN; HUMANS; LEUKEMIA, T-CELL, ACUTE; LIGANDS; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION; VIDARABINE;

EID: 0030744833     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Miesfield, R. L. The structure and function of steroid receptor proteins. Crit. Rev. Biochem. Mol. Biol., 24: 101-117, 1989.
2. Spaderi, S., Pedarali, N. G., Focher, F., Montecucco, A., Bordoni, T., Geroni, C., Giuliani, F. C., Ventrella, G., Arcomone, F., and Ciarocchi, G. DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs. Anticancer Res., 6: 935-940, 1986.
3. Smith, G., Duch, D. S., Dev, I. K., and Kaufmann, S. H. Metabolic effects and kill of human T-cell leukemia by 5-deazaacyclotetrahydrofolate, a specific inhibitor of glycineamide ribonucleotide transformylase. Cancer Res., 52: 4895-4903, 1992.
4. Smets, L. A. Programmed cell death (apoptosis) and response to anticancer drugs. Anticancer Drugs, 5: 3-9, 1994.
5. Friesen, C., Herr, I., Krammer, H. P., and Debatin, K. M. Involvement of the CD95 (Apo-1/fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2: 574-578, 1996.
6. Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W., Stremmel, W., Krammer, H. P., and Galle, P. R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (Apo-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest., 99: 403-413, 1997.
7. Tewari, M., and Dixit, M. V. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the cowpox virus crmA gene product. J. Biol. Chem., 270: 3255-3260, 1995.
8. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. Human ICE/CED-3 protease nomenclature. Cell, 87: 20, 1996.
9. Komiyama, T., Ray, A., Pickup, D. J., Howard, A. D., Thornberry, E. P., Peterson, E. P., and Salvesen, G. J. Inhibition of Interleukin-1β-converting enzyme by the cowpox virus protein CrmA: an example for cross class inhibition. J. Biol. Chem., 269: 19331-19339, 1994.
10. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rouke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, H. P., Peter, M. E., and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95(Fas/Apo-1) death-inducing signaling complex. Cell. 85: 817-827, 1996.
11. Quan, L. T., Caputo, A. B., Bleackley, R. C., Pickup, D. J., and Salvesen, G. S. Granzyme B is inhibited by the cowpox virus serpine cytokine response modifier A. J. Biol. Chem., 270: 10377-10379, 1995.
12. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillantcourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
13. Orth, K., Chinnaiyan, A. M., Garg, M., Froehlich, C. J., and Dixit, V. M. The CED-3/ICE-like protease Mch-2 is activated during apoptosis and cleaves the death substrate lamin. J. Biol. Chem., 271: 16443-16446, 1996.
14. Sirinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. Molecular ordering of the Fas apoptotic pathway: the Fas/Apo-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA, 93: 14486-14491, 1996.
15. Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S., and Flavell, R. A. Altered cytokine export and apoptosis in mice deficient in interleukin-1β-converting enzyme. Science (Washington DC), 267: 2000-2003, 1995.
16. Smith, D. J., McGuire, M. J., Tocci, M. J., and Thiele, D. L. IL-1β convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent and Fas-independent CTE effector mechanisms. J. Immunol., 158: 163-170, 1997.
17. Geley, S., Hartman, B. L., Kapelari, K., Egle, A., Villunger, A., Heidacher, D., Greil, R., Auer, B., and Kofler, R. The interleukin-1β-converting enzyme inhibitor CrmA prevents Apo-1/Fas-but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells. FEBS Lett., 402: 36-40, 1997.
18. Kondo, S., Banara, B. P., Morimura, T., Tackeuchi, J., Yuan, J., Akbasak, A., and Barnett, G. H. Interleukin-1β-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. Cancer Res., 55: 6166-6171, 1995.
19. Datta, R., Banach, D., Kojima, H., Talanian, R. V., Alnemri, E. S., Wong, W. W., and Kufe, D. W. Activation of the CPP32 protease in apoptosis induced by 1-β-D-arabino-furanosylcysteine and other DNA-damaging agents. Blood, 88: 1936-1943, 1996.
20. Lotem, J., and Sachs, L. Differential suppression hy protease inhibitors and cytokines of apoptosis induced by wild-type p53 and genotoxic agents. Proc. Natl. Acad. Sci. USA, 93: 12507-12512, 1996.
21. Adjei, P. N., Kaufmann, S. H., Leung, W. Y., Mac, F., and Gores, G. J. Selective induction of apoptosis in Hep3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. Clin. Invest., 98: 2588-2596, 1996.
22. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
23. Smith, K. G. C., Strasser, A., and Vaux, D. L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/Apo-1)-transduced apoptosis but does not cause lymphadenopathy or autoimmune disease. EMBO J., 15: 5167-5176, 1996.
24. L antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res., 57: 62-67, 1997.
25. Aggarwal, B. B., Singh, S., LaPushin, R., and Totpal, K. Fas antigen signal proliferation of human diploid fibroblast and its mechanism is different from tumor necrosis factor. FEBS Lett., 364: 5-8, 1995.
26. Richardson, B. C., Lalwani, N. D., Johnson, K. J., and Marks, R. M. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol., 24: 2640-2645, 1994.
27. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., and Lynch, D. H. Fas-transduced activation signals in normal human T lymphocytes. J. Exp. Med., 178: 2231-2235, 1993.
28. Rathmell, J. C., Townsend, S. E., Xu, J. C., Flavell, R. A., and Goodnow, C. C. Expansion or elimination of B cells in vivo: dual roles for CD-40 and Fas (CD95) ligands modulated by the B-cell antigen receptor. Cell, 87: 319-330, 1996.
29. Mapara, M. Y., Bargou, R., Zugck, C., Dohner, H., Ustaoglu, F., Jonker, R. R., Krammer, P. H., and Dorken, B. Apo-1-mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol., 23: 702-708, 1993.